VisMederi Holding
Improving human health
Vismederi Holding
Vismederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of Vismederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.
Revenues
Employees
Global Partnerships
Vismederi Holding: latest news
All the news of the group
VisMederi Recognized Among Top 300 Fastest-Growing Companies of 2023 by Financial Times and Statista
New Collaborative Research between VisMederi Group and GVGH on Enteric Fever Published in Frontiers in Immunology
New Publication: Advancing Vaccine Research with GVGH – A Novel Assay for Quantifying Anti-Vi IgG in Clinical Sera
The first workshop involving Trialect and the Vismederi Foundation is underway!
VisMederi Foundation at the Bright-Night 2024
VisMederi will be present at the World Vaccine Congress Europe 2024 in Barcelona
Collaboration Agreement Signed Between Trialect Inc. USA and Fondazione VisMederi
A new study suggests that antibodies produced by vaccinia-based vaccines may neutralize the Monkeypox virus
VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP
Important international study in the field of Monkey Pox and Vaccinia Virus
Where we
are
The
founder
Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.